Key result
Pre-PCI VA-ECMO in AMICS is linked to ~68% lower 30-day mortality versus post-PCI initiation.
Why the study?
The optimal timing for initiating VA-ECMO in patients with acute myocardial infarction complicated by cardiogenic shock remains unclear.
Does initiating VA-ECMO before primary PCI reduce mortality compared to initiating it after primary PCI in patients with acute myocardial infarction complicated by cardiogenic shock?
Cohort (n=113)
No
Does initiating VA-ECMO before primary PCI reduce mortality compared to initiating it after primary PCI in patients with acute myocardial infarction complicated by cardiogenic shock?
Hazard Ratio: 0.32 (95% CI 0.17–0.6)
Absolute Event Rate: 29.2% vs 61%
p-value: p=<0.001
Initiating VA-ECMO before primary PCI in patients with infarct-related cardiogenic shock is associated with significantly lower short- and long-term mortality compared to post-PCI initiation.
Optimal VA-ECMO timing in AMICS remains unclear; retrospective data leaves open whether pre-PCI initiation improves survival.
The optimal timing for venoarterial extracorporeal membrane oxygenation (VA-ECMO) initiation in patients with acute myocardial infarction complicated by cardiogenic shock (AMICS) remains unclear. This study evaluated whether initiating VA-ECMO before primary percutaneous coronary intervention (PCI) improves survival compared with post-PCI initiation in patients with AMICS. We performed a single-center retrospective cohort study using registry data from 113 patients with AMICS who received VA-ECMO. The patients were classified into ECMO pre-PCI (n = 72) and ECMO post-PCI (n = 41) groups. The 30-day mortality rate in the ECMO pre-PCI group (29.2%) was lower than that in the ECMO post-PCI group (61.0%) (adjusted hazard ratio [HR], 0.32; 95% confidence interval [CI], 0.17–0.60; p < 0.001) and remained consistent across most subgroups. The ECMO pre-PCI group was also associated with lower in-hospital (27.8% vs . 61.0%; adjusted odds ratio, 0.20; 95% CI, 0.08–0.48; p < 0.001), 180-day (36.1% vs . 63.4%; adjusted HR, 0.36; 95% CI, 0.20–0.65; p < 0.001), and 360-day (40.3% vs . 65.9%; adjusted HR, 0.37; 95% CI, 0.21–0.66; p <0.001) mortality. In selected patients with AMICS, initiating VA-ECMO support before primary PCI may reduce short- and long-term mortality compared with initiating support after primary PCI. These findings highlight the potential significance of early hemodynamic stabilization and warrant further prospective studies.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2026) conducted a cohort in Acute myocardial infarction complicated by cardiogenic shock (AMICS) (n=113). VA-ECMO initiation before primary PCI vs. VA-ECMO initiation after primary PCI was evaluated on 30-day mortality (adjusted HR 0.32, 95% CI 0.17-0.60, p=<0.001). Initiating VA-ECMO before primary PCI in patients with AMICS was associated with lower 30-day mortality compared to post-PCI initiation (29.2% vs 61.0%; adjusted HR 0.32; 95% CI 0.17-0.60; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: